Figure 4. Meta-analysis of the association of CRP and clinical outcomes of patients with urothelial carcinoma or bladder cancer.
(A): CRP and CSS in patients with bladder cancer; (B) CRP and OS in patients with bladder cancer; (C) CRP and CSS in patients with upper urinary tract urothelial carcinoma.